¹B°Ê¥Í²z¾Çºô¯¸ ·|­û¡G¥¼µn¿ý¡@µn¤J¡@§Ñ°O±K½X¡@¥Ó½Ð¥[¤J·|­û ¡@·|­û9724 ¡@³¡¸¨®æ5¡@¡@


¹B°Ê¥Í²z¶g°T ¹B°Ê¥Í²z¶g°T(³Ì·s¦^À³) ¦^¶g°T­º­¶

¹B°Ê¥Í²z¶g°T¹B°Ê¥Í²z¶g°T¹q¤l³ø
Online ISSN : 1814-7712
ª©Åv©Ò¦³ ¥¼¸g¦P·N ½Ð¤ÅÂà¸ü©Î¸`¿ý

¹B°Ê±`ÃÑ °V½m·§½× ¯à¶q¨Ó·½ ©I§l´`Àô ¦Ù¦×°©Àf ¹B°ÊÅé¯à °V½m¤èªk
¨­Åé²Õ¦¨ ¹B°ÊÀç¾i ¹B°ÊÀô¹Ò ¹B°Ê¶Ë®` ¬ã¨s¤èªk ºô¯¸µo®i ¬ÛÃö°T®§

¥DÃD¡G¨­Å鬡°Ê»P¸£³¡°·±d
µo¨¥ : ¤è¶i¶© ®É¶¡ : 19/08/10(22:33:11) From : 101.8.131.209 ¤ÀÃþ : °V½m·§½×
¹B°Ê¥Í²z¶g°T(²Ä384´Á)

¨­Å鬡°Ê»P¸£³¡°·±d(August 10, 2019)

¤è¶i¶© ¥xÆW®v¤jÅé¨|¨t¦WÅA±Ð±Â

³ü¡B«e¨¥

¡@¡@ÀY¸£¬O¨­Å骺¤¤¼Ï¡A¤@­Ó¤Hªº¤º¥~ªí²{¡A¥]¬A¥Í¬¡«~½è¡B»{ª¾¥\¯à¡B¤u§@ªí²{©M¾Ç²ß®Ä²vµ¥¡A³£»P¸£³¡°·±d (brain health) ¦³µÛ±K¤£¥i¤ÀªºÃö«Y¡CµM¦Ó¡AÀHµÛ¦~ÄÖ¼Wªø¡A¨­Å鬡°Ê (physical activity) ´î¤Ö¡B¨­Åé¥\¯à©MÅé¾A¯à (physical fitness) ³vº¥°I°h¡A¿©±wºC©Ê¯e¯f°ÝÃD´N±µ¿æ¦Ó¨Ó¡A³Ì«á³s¥¢´¼¤]¥i¯à§ä¤Wªù¡C¾¨ºÞ¦p¦¹¡A¤w¸g¦³³\¦hªº¬ã¨sÅã¥Ü¡A³W«ß¨­Å鬡°Ê¥i¥H³z¹L¦hºØ¤è¦¡§ïµ½¸£³¡°·±d¡A¦Ó­°§C¿©±w¥¢´¼¯gªº­·ÀI (Tyndall et al., 2018)¡C

¡@¡@¥»¤åªº­«ÂI¦b±´°Q¨­Å鬡°Ê»P°ªÄ̸֪£³¡°·±dªºÃö«Y¡A¤×¨ä¬O¥¢´¼¯g¡C¨Ì¾Ú°ê¤º¥¢´¼¯g¬y¦æ¯f¾Ç½Õ¬d (¥Á°ê100¦~)¡A¥H¤Î¤º¬F³¡107¦~12¤ë©³¤H¤f²Î­p¸ê®Æ¡A¥xÆW65·³¥H¤W¦Ñ¦~¤H¦û¥þ¤H¤fªº14.56 %¡A¨ä¤¤¦³18.23 %¬O»´·L»{ª¾»ÙêªÌ¡A7.86 %¬O¥¢´¼¯gªÌ¡C¾ãÅé¦Ó¨¥¡A65·³¥H¤Wªº¦Ñ¤H¨C12¤H¬ù¦³1¦ì¥¢´¼¡A¦Ó80·³¥H¤W¡A¨C5¤H§Y¦³1¦ì¥¢´¼ªÌ (¥xÆW´¼¯g¨ó·|¡A¥¢´¼¤H¤fª¾¦h¤Ö¡A2018¡A¨ú¦Û http://www.tada2002.org.tw)¡A¥Ñ³o¨Ç¸ê®ÆÅã¥Ü¡A°ªÄ̸֪û®e©ö¿©±w¥¢´¼¯g¡A¦~¬ö¶V¤j¡A¿©±w²v¶V°ª¡C

¡@¡@¥¢´¼¯g¬O³\¦h¯gª¬²Õ¦X¡A¦Ó«D³æ¤@¯e¯f¡A¯u¥¿¿©±w­ì¦]¤£¸Ô¡AÁ{§Éªí²{¬O¸£¯«¸g¡B¦åºÞ¥\¯à¥¢±`©Î¨âªÌ©Ò¤Þ°_ªº¯fÅÜ¡A¾É­P¸£¯«¸gÅÖºû³vº¥Äñµ²µäÁY¡A¦]¦Ó¥¢¥h°O¾Ð»P»{ª¾¯à¤O¡A³y¦¨»y¨¥©M±¡ºü»Ùê¡AÄY­«®É·|¥¢¥h¦Û§Ú·ÓÅU»P¿W¥ß¥Í¬¡ªº¯à¤O¡C¥¢´¼¯gªÌ¤¤¬ù¦³60-70%¬Oªü¯÷®üÀq¯g¡C¦b¤H¤f¦Ñ¤Æªº®É¥N¡A¥¢´¼¤H¤f¤ñ²v·|¶V¨Ó¶V¦h¡A³y¦¨®a®x¤ÎªÀ·|ÄY­«ªº°ÝÃD¡A¹ê¤£®e¤pòó¡A¦]¦¹¡A¸£³¡°·±dijÃD¤]¤Þµo¥@¬É¦U°ê°ª«×ªºÃöª`¡C

¡@¡@¥Ø«e¹w¨¾©Î§ïµ½¥¢´¼¯gªº¤èªk¨ÃµL¯S®ÄÃÄ¡AªAÃÄ¥u¯à¼È®Éºû«ù±wªÌ¦Û§Ú·ÓÅU¯à¤O¡A´î»´·ÓÅUªÌªº­t¾á¡A¦ý®ÄªG¦³­­¡C¨­Å鬡°Ê¤w³Q»{¬°¬O§ïµ½»{ª¾¥\¯à³Ì¦³®Äªº¤èªk¤§¤@ (Erickson et al., 2019)¡Aªñ´Áµoªíªººî¦X¤åÄm©Î³ø§i®Ñ¡A¬Ò«ü¥X¨­Å鬡°Ê¥i¥H¥Ñ³\¦h¤è¦¡¨Ó§ïµ½¸£³¡°·±d (Erickson et al., 2019; Tyndall et al., 2018)¡C¾¨ºÞ¦s¦b³\¦h¬ì¾ÇÃÒ¾Ú¡A¦ý¥Á²³¹ï³oijÃDÁÙ¬O¤£«ÜÁA¸Ñ¡A¦]¦¹¡A¥»¤å±N°w¹ï¨­Å鬡°Ê§ïµ½¸£³¡°·±dªº¬ÛÃöijÃD¥[±j»¡©ú¡A¥]¬A¯q³B¡B¥i¯à¾÷Âà¡B¹B°Êµ¦²¤»P¤èªk¡A§Æ±æ¹ïÃö¤ß¸£³¡°·±dªº¥Á²³¦³©Ò§U¯q¡C

¶L¡B¨­Å鬡°Ê¹ï¸£³¡°·±dªº¯q³B

¡@¡@¥»¤å©Ò°Q½×ªº¨­Å鬡°Ê¡A¬O«ü¨­Åé¦Ù¦×¦¬ÁY²£¥Í¯à¶qªº¬¡°Ê¡A¥]¬A¹B°Ê (¦p¨«¸ô¡Bªý¤O°V½m©M¦ù®i¾Þµ¥) ©M¤é±`¬¡°Ê (¦p®a°È©Î¶éÃÀµ¥)¡A¤@¯ë¦Ó¨¥¡A¨­Å鬡°Ê¶q¶V¦h¡AÅé¾A¯à(¦p¤ßªÍ¥\¯à©M¦Ù¦×¾A¯à) »P°·±dª¬ªp¶V¦n¡C¦³Ãö¨­Å鬡°Ê§ïµ½»{ª¾¥\¯à»P¸£³¡°·±dªº¤åÄm«Ü¦h¡A¥»¤å¥H¨â½g³Ìªñ¸û¨ã¥Nªí©Êªº¤åÄm¨Ó¥[¥H±Ô­z¡C¨ä¤@¬O2018¬ü°ê¨­Å鬡°Ê«ü¾É©e­û·| (2018 Physical Activity Guideline Advisory Committee, 2018 PAGAC) ºî¦X¾ã²zªº³ø§i®Ñ¡A¨ä¤º®e§ó·s¨Ã¸É¥R¤F10¦~«e (2008¦~) ¬ü°ê°·±d»PªA°È³¡ (department of health and human service) ¤½¥¬ªº¡u¨­Å鬡°Ê»P°·±d (physical activity and health)¡v¸ê®Æ¡A¥]¬A­º«×´£¥X¨­Å鬡°Ê¹ï©ó¸£³¡ªº¥Íª««ü¼Ð (¦p¸£³¡®e¿n) ¦³¥¿­±ªº¯q³Bªº½×ÂI¡C¥t¤@½gºî¦X¾ã²z¬ã¨s (Erickson et al., 2019)¡A¤]°w¹ï¤U¦CijÃD¡A¶i¤@¨B±´°Q¨­Å鬡°Ê©M¸£³¡°·±dªºÃö«Y¡A¥]¬A¡G1. ¨­Å鬡°Ê¤¶¤J¬O§_¯à´£¤É»{ª¾¥\¯à»P¸£³¡°·±d ? 2. ¨­Å鬡°Ê¹ï©ó»{ª¾»ÙêªÌ¬O§_¦³©ÒÀ°§U ? 3. °Ñ»P¸û¦h¨­Å鬡°Ê¬O§_¯à´î§C°ªÄ֪̻{ª¾»Ùê©M¥¢´¼ªº­·ÀI? ³o¨â½g¤åÄm¨Ì¾Ú¹L¥h¬ã¨sªºÄYÂԫשMµ²ªG¡A±Nµ²½×¤À¬°¡G1. µLªkÂkÃþ (grade not assignable); 2. ¦³­­ (limited) ÃÒ¾Ú; 3. ¤¤µ¥ (moderate) ÃÒ¾Ú; 4. ¥R¥÷ (strong) ÃÒ¾Úµ¥¥|Ãþ§O¡A¯÷±N¥R¥÷©M¤¤µ¥ÃÒ¾Ú¥H¤Wªº¬ã¨sµ²½×¾ã²z¦p¤U¡G

(¤@) ¥R¥÷ÃÒ¾Ú¡G
1. ³æ¦¸¤¤µ¥¦Ü¿E¯P¹B°Ê¹ï©ó»{ª¾¦³µu¼Èªº§ïµ½®ÄªG¡A¥]¬Aª`·N¤O¡B°O¾Ð¤O¡B´¹Åé´¼¤O(crystallized intelligence, ¤@¯ë¯àªø´Á²Ö¿nªº´¼¤O©Î±`ÃÑ)¡B³B²z³t«×©M°õ¦æ±±¨î¯à¤O¡C
2. ¨­Å鬡°Ê¯à§ïµ½»{ª¾¥\¯à¡A¹ï©ó¦Ñ¦~¤H©M¤p«Äªº®ÄªG§ó¤j¡C
3. ¸û¦hªº¨­Å鬡°Ê»P´î§C»{ª¾°I°h­·ÀI©M¥¢´¼¦³¬ÛÃö¡A¥]¬Aªü¯÷®üÀq¯g¡C


(¤G) ¤¤µ¥ÃÒ¾Ú¡G
1. ¨­Å鬡°Ê¶V¦h¡A»{ª¾¥\¯à§ïµ½¶V¦h¡A¥]¬A¾Ç·~ªí²{¡B¯«¸g¤ß²z´úÅç (¥]¬A¨Æ±¡³B²z³t«×¡B°O¾Ð¡B°õ¦æ¥\¯à©M¥¢´¼­·ÀI) µ¥¡C
2. ³\¦h¹B°Ê¹ï¸£³¡°·±d¬Ò¦³®Ä¡A¥]¬A¦³®ñ¹B°Ê (¦p§Ö¨«)¡Bªý¤O°V½m¡B·ì¦÷©M¹CÀ¸©Ê¹B°Ê(play activities) µ¥¡C
3. ªø´Á¤¤µ¥¦Ü°ª±j«×ªº¹B°Ê°V½m¹ï©ó¤­¤Q·³¥H¤W¤¤¦Ñ¦~¤Hªº»{ª¾©M¸£³¡°·±d¸û¦³¯q³B¡C
4. ¤¤µ¥¦Ü¿E¯Pªº¨­Å鬡°Ê°V½m (¤¶¤J) ¯à§ïµ½¥¢´¼±wªÌªº»{ª¾¯à¤O¡C
5. »{ª¾»Ùê©Î¯e¯f±wªÌ±q¨Æ¤¤µ¥¦Ü¿E¯P¨­Å鬡°Ê¹ï©ó»{ª¾¥\¯à¦³¥¿­±®ÄªG¡C
6. ¤¤µ¥¦Ü¿E¯P¨­Å鬡°Ê¡A¯à§ïµ½¸£³¡°·±d©M»{ª¾ªº¥Íª««ü¼Ð (biomarkers)¡A¦p¸£®e¶q¼W¥[¡C¨­Å鬡°Ê¤¶¤J§ïµ½ªº¥Íª««ü¼Ð©ó¤p«Ä©M¦Ñ¦~¤H±Ú¸s¸û¬°©úÅã (¤ñ¨ä¥L±Ú¸s)¡C


°Ñ¡B¨­Å鬡°Ê«OÅ@¸£³¡°·±dªº¾÷Âà

¡@¡@¨­Å鬡°Ê¯à°÷§ïµ½»{ª¾¥\¯à©M¸£³¡°·±d¥i¯à©Ê¡A°ò¥»¤W¬O¨Ì¾Ú¯«¸g¥Íª«­ì«h(neurobiological principle) ¹B§@¡A¸£³¡¬ÛÃöªº²Ó­M©M¤À¤lªø´Á¨ü¨ì¨­Å鬡°Êªº¨ë¿E©Î¼vÅT¡A¦Ó²£¥Í¾AÀ³»P§ïÅÜ (Erickson et al., 2019)¡C¸£³¡¨ü¨ì³\¦h¦]¯Àªº¼vÅT¡A¦Ó³o¨Ç¦]¯À·|¥æ¤¬§@¥Î¦Ó¼vÅT°·±d¡A¦]¦¹©y¥Ñ¦h¤¸¨¤«×¨Ó±´°Q¨ä¥i¯àªº¾÷Âà©Î§@¥Î (2018 PAGAC, 2018; Tyndall et al., 2018)¡A³W«ß¹B°Ê¥i¥H§ïµ½°ªÄ֪̪º¥Í²z°·±d¡B¥Íª««ü¼Ð¡B¤ß²z°·±d©MºÎ¯v¡A¦Ó¯à´£¤É»{ª¾¥\¯à»P¸£³¡°·±d¡A¥»¤å´N³o´X­Ó»â°ì¥[¥H±Ô­z (¦pªí1)¡A¨Ã¦C¥X¬ÛÃöªº¬ã¨s¡C

ªí1 ³W«ß¨­Å鬡°Ê¹ï°ªÄ̸֪£³¡°·±dªº¯q³B
§ïµ½»â°ì³W«ß¨­Å鬡°Ê¤§¯q³B»¡©ú
¤@¡B
¥Í²z°·±d
1. ¼W¥[³Ì¤jÄá®ñ¶q
2. ¼W¥[¸£³¡¦å¬y¶q
3. ¼W¥[®ü°¨°j®e¿n
¦¨¦~«á³Ì¤jÄá®ñ¶q¡B¸£¦å¬y¶q»P®ü°¨°j®e¿n·|³vº¥´î¤Ö¡A­P¼vÅT»{ª¾¥\¯à¡A¦Ó³W«ß¹B°Ê«h¥i¥H§ïµ½³o¨Ç¥Í²z«ü¼Ð¡C
¤G¡B
¥Íª««ü¼Ð
1. ´î§Cµoª¢«ü¼Ð¡G´î§C²Ó­M¿E¯À (¦p¥Õ¦å²y¤¶¯À-6¡B¸~½FÃa¦º²Ó­M(TNF-) ©MC¤ÏÀ³³J¥Õ(CRP)¡C
2. ´î§C®ñ¤ÆÀ£¤O¡C
3. ¼W¥[¦¨ªø¦]¤l: ¼W¥[¦¨ªø¶Pº¸»X (GH)¡BÃþ¯Ø®q¯À¦¨ªø¦]¤l (IGF-1)¡B¸£³¡´þ¾i¦]¤l (BDNF)¡B¯«¸g¦¨ªø¦]¤l (NGF) ©M¤º¥Ö¦åºÞ¦¨ªø¦]¤l (VEGF)¡C
4. §ïµ½¥NÁ¯g­Ô¸s¡G§ïµ½°ª¦åÀ£¡B°ª¦å¿}¡B¸¡³¡¯×ªÕ¡B¤T»Ä¥Ìªo¯×©M°ª±K«×¯×³J¥ÕÁx©T¾J¡C
°ªÄ֪̦³¸û°ªªºµoª¢«ü¼Ð¡B®ñ¤ÆÀ£¤O©M¥NÁ¯g­Ô¸s¡A¥[¤W¦¨ªø¦]¤lªº¤Àªc¸û¤Ö¡A·|­°§C¸£¯«¸g©M¦åºÞ²Ó­Mªº§Î¦¨©Î¥\¯à¡A¦]¦Ó¼vÅT»{ª¾¥\¯à¡A©Î¼W¥[¿©±w¥¢´¼ªº­·ÀI¡C³W«ß¨­Å鬡°Ê¥i¥H§ïµ½³o¨Ç¥Íª««ü¼Ð¡A¦Ó«P¶i¸£³¡°·±d¡C
¤T¡B
¤ß²z°·±d©MºÎ¯v«~½è
1. §ïµ½¤ß²z°·±d¡G§ïµ½ªq³à©MµJ¼{¡C
2. §ïµ½ºÎ¯v«~½è
¤ß²z°·±d (¤×¨ä¬OµJ¼{©Mªq³à) ©MºÎ¯v«~½è©M»{ª¾¥\¯à¦³Ãö¡A°ªÄ֪̪ºµJ¼{©Mªq³àµ{«×¸û°ª¡A·|´î§C»{ª¾¥\¯à¡C¨­Å鬡°Ê¥i¥H§ïµ½¤ß²z°·±d©MºÎ¯v«~½è¡C


¤@¡B§ïµ½¥Í²z°·±d

¡@¡@³W«ß¨­Å鬡°Ê»P¹B°Ê¥i¥H§ïµ½³Ì¤jÄá®ñ¶q¡B¸£³¡¦å¬y¶q©M¼W¥[¸£³¡®ü°¨°j®e¿n¡C

1. ¼W¥[³Ì¤jÄá®ñ¶q
¡@¡@¦¨¦~«áÀHµÛ¦~ÄÖªº¼Wªø¡A³Ì¤jÄá®ñ¶q (©Î¤ßªÍ¥\¯à) ·|³vº¥´î¤Ö¡A¨C¤Q¦~¬ù­°§C10%¡A¥D­n­ì¦]¬O¨­Å鬡°Ê¤£¨¬»P¤ß¦åºÞ¨t²ÎÅÜ®t¡C¤@¯ë¦¨¦~¤Hªº³Ì¤jÄá®ñ¶q¬ù40 ml/kg/min¡A¦Ñ¦~¤Hªº³Ì¤jÄá®ñ¶q¦p³vº¥´î¤Ö¦Ó§C©ó15 ml/kg/min¡A«hµLªk¿W¥ß±q¨Æ¤é±`¬¡°Ê (Bouazizw et al., 2016)¡C³W«ß±q¨Æ¦³®ñ¹B°Ê¡A¥i¥H´£¤É³Ì¤jÄá®ñ¶q»P¸£³¡¦å¬y¶q¡A¦Ó¾Ö¦³¸û¨Îªº»{ª¾¯à¤O¡A´î¤Ö¿©±w¥¢´¼¯g¤§­·ÀI (Brown et al., 2010)¡C
¡@¡@¨­Å鬡°Ê¶q»P³Ì¤jÄá®ñ¶q¦³¬ÛÃö¡A°lÂܩʬã¨s«ü¥X¡A¨S¦³¥¢´¼°ªÄ֪̱q¨Æ¸û°ªªº¨­Å鬡°Ê¶q¡A©ó¥|¦~¤º¿©±wªü¯÷®üÀq¯g (¥¢´¼¯gªº¤@ºØ) ªº¤ñ²v¸û§C¡A¨C¤Ñªº¨­Å鬡°Ê¶q»P»{ª¾¥\¯à¦³Ãö (Buchman et al., 2012)¡C¸û¨Î³Ì¤jÄá®ñ¶q©Î¤ßªÍ¥\¯à¹ï©ó¸£³¡°·±d²£¥Í¥¿­±®ÄªG¡A³¡¤À­ì¦]¦ü¥G¬O³z¹L§ïµ½¸£³¡ªº¦åºÞ¥\¯à¦Ó³y¦¨ (Gill et al., 2015)¡C

2. ¼W¥[¸£³¡ªº¦å¬y¶q
¡@¡@¸£³¡­«¶q¶È¥e¥þ¨­Åé­«2%¡A«o¨Ï¥Î15%ªº¤ß¿é¥X¶q¡A¤Î»Ý­n20%ªºÀç¾i©M®ñ®ð¡A¸£³¡¯Ê¥F®ñ®ð©ÎÀç¾i®É¡A¦å²G·|­«·s¤À°t¡AÅý¸£³¡Àò±o¨¬°÷¦å²G¶q (Attwell et al., 2010)¡C¦¨¦~¤H¦wÀR®É¤§¸£¦å¬y¶q¡A¨C¤Q¦~¬ù·|´î¤Ö5%¡A¦p¸£³¡¦åºÞ¥\¯à¤£¨Î¡AµLªk¿é°e¨¬°÷¦å¬y¶q¡A®ñ®ð©MÀç¾i¯À¨ÑÀ³¤£¨¬¡A±N·|²£¥Í¸£³¡°·±d°ÝÃD (Davenport, Hogan, Eskes, Longman, & Poulin, 2012)¡C
¡@¡@°ªÄ֪̤ߦåºÞ¯e¯fªº¦MÀI¦]¯À©M®ñ¤ÆÀ£¤O¼W¥[¡A¾É­P¦åºÞ¥\¯à­°§C©M¸£¦å¬y¶q¤£¨¬¡A¹L¥h³\¦h¬ã¨s«ü¥X³W«ß¦³®ñ¹B°Ê¡A¯à´£¤É°ªÄ֪̳̤jÄá®ñ¶q»P¸£³¡¦å¬y¶q¡A©Î«O¦s¸£¦å¬y¶q (Tyndall et al., 2018)¡C

3. ¼W¥[¸£³¡®ü°¨°j®e¿n
¡@¡@¹L¥h¬ã¨sµ²ªG«ü¥X (14½g¤¤¦³9½g)¡A¦³®ñ¹B°Ê·|¼W¥[°ªÄ֪̮ü°¨°jªº®e¿n (Erickson et al., 2019)¡A¨ã¦³¤¤µ¥µ{«×ªº¬ã¨sÃÒ¾Ú¡C¨Ò¦p¡G±q¨Æ¤»­Ó¤ëªº¦³®ñ¹B°Ê°V½m«á¡A»´«×»{ª¾»Ùê°ªÄÖ¤k©Êªº®ü°¨°j©M«eÃB¸­®e¿n¼W¥[¡A§Y¨Ï¬O»´«×»{ª¾»Ùê¡A®ü°¨°jªº¯«¸g¥i¯à·|¦]¬°¦³®ñ¹B°Êªº¨ë¿E¦Ó¦A¥Í (Ten et al., 2015)¡C
¡@¡@¦Ñ¤Æ·|­°§C¸£¯«¸g²Ó­M¦A¥Í¯à¤O¡B¥[³t¯«¸g¦º¤`©M©µ¿ð¨ü¶Ë«áªº´_¤¸¯à¤O¡A¦]¦Ó¼vÅT¸£³¡µ²ºc»P»{ª¾¥\¯à¡C¬ã¨sÅã¥Ü¡A°·±d¦Ñ¦~¤Hªº®ü°¨°j»P«eÃB¸­®e¿n¤ñ°·±d¦~»´¤H¤p¡A©ó30·³¥H«á¡AÀHµÛ¦~ÄÖªº¼W¥[¦Ó³vº¥µäÁY¡A°·±d¨S¦³¥¢´¼¦Ñ¦~¤H®ü°¨°j®e¿nªºµäÁY³t«×¡A¨C¦~¬ù´î¤Ö1-2% (Tyndall et al., 2018)¡C®ü°¨°j¬O°O¾Ð¥\¯àªº­«­n³¡¦ì¡A¤]¬O»´«×»{ª¾»ÙêªÌ³Ì¦­¨ü¼vÅTªº»{ª¾°Ï°ì(Erickson et al., 2011)¡C

¤G¡B§ïµ½¥Íª««ü¼Ð

¡@¡@³W«ß¨­Å鬡°Ê¯à§ïµ½¦Ñ¦~¤H¸£³¡ªº¥Íª««ü¼Ð¡A¥]¬A´î§Cµoª¢«ü¼Ð(inflammatory markers)¡B´î¤Ö®ñ¤ÆÀ£¤O (oxidative stress)¡B¼W¥[¥Íªø¦]¤l (growth factors) ©M§ïµ½¤ß¦åºÞ¯e¯f¦MÀI¦]¯À (Tyndall et al., 2018)¡C

1. ´î§Cµoª¢«ü¼Ð
¡@¡@ºC©Ê»´«×µoª¢¬O¦Ñ¤Æ¹Lµ{ÆZ´¶¹Mªº²{¶H¡A¥¦»P³\¦h¬ÛÃö¯e¯f¦³Ãö¡A¹³¤ß¦åºÞ¯e¯f»P¥¢´¼¡Aµoª¢«ü¼Ð¥]§tµoª¢©Êªº²Ó­M¿E¯À (cytokine)¡A¦p¥Õ¦å²y¤¶¯À 6 (IL-6)¡B¸~½FÃa¦º²Ó­M£\ (TNF£\)¡BC¤ÏÀ³³J¥Õ (CRP) µ¥¡C·U¨Ó¶V¦hªº¬ã¨sÅã¥Ü¡AºC©Ê»´«×µoª¢»P¯«¸g»{ª¾¥\¯à°I°h (¥]¬Aªü¯÷®üÀq¯g) ¦³Ãö¡A¥i¯àÂǥѸ£¯«¸g¦º¤`¡B¯«¸g¶Ç¾Éª«½è¥¢½Õ©M¦å¸£«Ì»Ù¥¢±` (blood-brain barrier dysfunction) µ¥¾÷Âà©Ò³y¦¨ (Hess & Smart, 2017)¡C
¡@¡@³\¦h¬ã¨sÅã¥Ü¡A¸û°ª¨­Å鬡°Ê¶q¦Ñ¦~¤Hªºµoª¢«ü¼Ð¸û§C (Tyndall et al., 2018)¡A¦ý¨­Å鬡°Ê¹ï©óµoª¢¨t²Îªº§ïµ½µ{«×­n¨Ì¹B°Ê¶q¡B±j«×©MÀW²vµ¥¦]¯À¦Ó©w¡C¦³¬ã¨s«ü¥X¨­Å鬡°Ê¶q¸û¦hªº¦Ñ¦~¤H¡A¦³¸û§CªºCRP¡BIL-6¡BTNF-£\ (Colbert et al., 2004)¡C¾ãÅé¦Ó¨¥¡A¸û¦hªº¨­Å鬡°Ê·|´î§C°ªÄ֪̪ºµoª¢«ü¼Ð¡A¦Ó¦³§U©ó¸£³¡°·±d¡C

2. ´î¤Ö®ñ¤ÆÀ£¤O
¡@¡@®ñ¤Æª«½è¬O²Ó­M¥NÁ¹Lµ{¤¤©Ò²£¥Íªº¦³¬rª«½è¡A¹L¦h®ñ¤Æª«½èªº²Ö¿n¡A·|²£¥Í®ñ¤ÆÀ£¤O¦Ó¹ï²Ó­M²£¥Í¶Ë®`¡C¤T¤Q·³«á¡A¸£³¡¦å¬y¶q¨C¦~·|´î¤Ö4 ml/min¡A¦Ó·í¸£³¡¦å¬y¶q¤£¨¬®É¡A·|¼W¥[®ñ¤ÆÀ£¤O (Stoquart et al., 2007)¡A´î¤Ö¤@®ñ¤Æ´á (NO) ªº§Î¦¨¡A¾É­P¦åºÞ¤º¥Ö¥\¯àªº¥¢±`¡A¦Ó¼vÅT¸£³¡°·±d¡C
¡@¡@³W«ß¨­Å鬡°Ê¥i¥H­×¥¿©Î±±¨î®ñ¤ÆÀ£¤O¹ï¦Ñ¦~¤Hªº¶Ë®`¡A¦Ó¤ßªÍ¥\¯à©Î³Ì¤jÄá®ñ¶q¸û¨Îªº°ªÄ֪̦³¸û¦hªº§Ü®ñ¤Æ»Ã¯À©M¸û§Cªº®ñ¤ÆÀ£¤O (Pialoux, Brown, Leigh, Friedenreich, & Poulin, 2009)¡C¨ä¥L¬ã¨s«ü¥X³W«ß¹B°Ê¥i¥H´î¤Ö®ñ¤ÆÀ£¤O¡B°Ê¯ßµw¤Æ©M¦åºÞµoª¢¡A¤]¯à´£¤É¦åºÞ¤º¥Ö¥\¯à (Davenport et al., 2012)¡C

3. ¼W¥[¦¨ªø¦]¤l (growth factors)
¡@¡@¦¨ªø¦]¤l¥ç¥iºÙ¬°¯«¸g´þ¾i¦]¤l¡A¬O¸£¯«¸g»P¦åºÞ¦A¥Í¡B¦¨ªø©Mºû«ù¥\¯à©Ò¥²»Ýªºª«½è¡C¦¨ªø¦]¤l¥D­n¥]¬A¦¨ªø¶Pº¸»X(GH)¡BÃþ¯Ø®q¯À¦¨ªø¦]¤l (IGF-1, ·|¨ë¿E¤Àªc¦¨ªø¶Pº¸»X)¡B¸£³¡´þ¾i¤À¤l(BDNF)¡B¯«¸g¦¨ªø¦]¤l (NGF) ©M¦åºÞ¤º¥Ö¦¨ªø¦]¤l (VEGF) µ¥¡A³o¨Ç¦¨ªø¦]¤lÀHµÛ¦Ñ¤Æ¦Ó´î¤Ö¤Àªc¡A¦Ó³W«ß¨­Å鬡°Ê¥i¥H¼W¥[©Î½Õ¾ã³o¨Ç¦¨ªø¦]¤lªºÄÀ©ñ©Î¥\¯à (Tyndall et al., 2018)¡C
¡@¡@±q¨Æ³æ¦¸¤T¤Q¤ÀÄÁ¤¤µ¥±j«×ªº¦³®ñ¹B°Ê©Îªý¤O°V½m¡A¥i¥H§ïµ½»´«×ª¾¯à»Ùê¦Ñ¦~¤Hªº»{ª¾ªí²{¡A³æ¦¸¦³®ñ¹B°Ê¥i¥H´£¤ÉBDNF and IGF1¡A¦Óªý¤O°V½m¥i¥H¼W¥[IGF1 (Tsai et al., 2018)¡C
¡@¡@±q¨Æ¨­Å鬡°Ê·|¦b¤W´å½Õ¾ã³o¨Ç¯«¸g´þ¾i¦]¤l¡A¥]¬A´£¤ÉIGF-1¡BBDNF©MVEGFµ¥¡A¦Ó¨­Å鬡°Ê©Ò¼W¥[©PÃ䪺IGF-1and VEGF ¿@«×¡A¦Ó¯à°÷¬ï¹L¦å¸£«Ì»Ù¥H¨ë¿E¯«¸g»P¦åºÞªº¦A¥Í¡A¯S§O¬O®ü°¨°j (Maass et al., 2016)¡C¦Ñ¦~¤H±q¨Æ¸û¦hªº¦³®ñ¹B°Ê·|´£¤É³Ì¤jÄá®ñ¶q¡A¤]·|¼W¥[®ü°¨°jªº BDNF and IGF-1¿@«×¡A¦Ó³o¨Ç¦¨ªø¦]¤l (BDNF & IGF-1) ¿@«×ªº¼W¥[©M´£¤É®ü°¨°jªº®e¿n©M»{ª¾¯à¤O¦³¥¿¬ÛÃö (Erickson et al., 2011)¡C
¡@¡@³z¹L¨­Å鬡°Ê¼W¥[¯«¸g´þ¾i¦]¤lªº¤Àªc¡A¦Ó«P¦¨¸£³¡¯«¸g»P¦åºÞªº¦A¥Í©M¥\¯à¡A¥i¯à¬O¼W¥[®ü°¨°j®e¿n¤Î§ïµ½»{ª¾¥\¯àªº­ì¦] (Tyndall et al., 2018)¡C

4. §ïµ½¥NÁ¯g­Ô¸s
¡@¡@¥NÁ¯g­Ô¸s¥]¬A¦å¿}¹L°ª¡B°ª¦åÀ£¡B¸¡³¡¯×ªÕ¹L¦h¡B¤T»Ä¥Ìªo¯×¹L°ª©M°ª±K«×¯×³J¥Õ¹L§Cµ¥¦MÀI¦]¯À¡A¦Ñ¤Æ·|¼W¥[¥NÁ¯g­Ô¸s©Î¤ß¦åºÞ¯e¯f¦MÀI¦]¯À¡A¦Ó¼W¥[¤ß¦åºÞ¯e¯f¡B¿}§¿¯f¡B¼~Æ{¯g¡BºC©ÊµÇŦ¯f©M¥¢´¼¯g¿©±w²v (Ng et al., 2016)¡C¬ã¨s«ü¥X¦³¥NÁ¯g­Ô¸s¦Ñ¦~¤Hªº¸£³¡¦å¬y¶q¤ñ°·±d¦Ñ¦~¤H§C 15%¡A³o²{¶H»P°O¾Ðªí²{¦³¬ÛÃö (Birdsill et al., 2013)¡C¥NÁ¯g­Ô¸s¸û®e©ö¼vÅTªº»{ª¾¥\¯à¥]¬A°O¾Ð¡BªÅ¶¡¯à¤O¡B³B²z³t«×©M°õ¦æ¥\¯à (Tyndall et al., 2018)¡C
¡@¡@³W«ß¨­Åé¹B°Ê¥i¥H§ïµ½¥NÁ¯g­Ô¸s¡A¥]¬A§ïµ½¦å¯×ªÕ¡B¦å¿}¡B°ª¦åÀ£©MÅé¯×ªÕ¡A¨Ã´î§C¤ß¦åºÞ¯e¯f¿©±w²v©M¾ãÅ馺¤`²v (U.S. Department of Health and Human Service, 2018)¡C

¤T¡B§ïµ½¤ß²z°·±d»PºÎ¯v«~½è

¡@¡@¦Ñ¤Æ·|¼vÅT¤ß²z°·±d©MºÎ¯v«~½è¡A¶i¦Ó¼vÅT¸£³¡°·±d¡A¦Ó³W«ß¨­Å鬡°Ê«h¥i¥H§ïµ½³o¨â­Ó¦]¯À¡C

1. §ïµ½¤ß²z°·±d
¡@¡@¤ß²z¦]¯À·|¼vÅT»{ª¾¯à¤O¡A¤]¬O¹w´ú¦Ñ¦~¤H»{ª¾°I°hªºÅܶµ¡A¯S§O¬OµJ¼{ (anxiety) ©Mªq³à (depression)¡C¬ã¨s«ü¥X»{ª¾¥¿±`°ªÄÖªÌ (75-95·³)¿©±w¼~Æ{©MµJ¼{¤ñ²v¤À§O¬°18.4%»P24.9%¡A§C©ó»´«×ª¾¯à»ÙêªÌ(36.2%»P46.8%)¡A¦³»´«×»{ª¾»ÙêªÌ¦p¦³µJ¼{¯gª¬¡A©ó¤T¦~¤º¦³83.3%¿©±wªü¯÷®üÀq¯g (AD)¡A¦p¨S¦³µJ¼{¿©±w²v«h¬°40.9%¡A¦Ó»{ª¾»P¤ß²z°·±dªÌ¿©±w²v¥u¦³6.1%¡Aªq³à©MµJ¼{ª¬ªp·|¼vÅT¥¼¨Ó¬O§_¿©±w¥¢´¼¯g (Palmer et al., 2007)¡A¼~Æ{¥i¯à¬O¿©±w¥¢´¼«eªº²{¶H¡A¦ÓµJ¼{¥i¯à¬O¯«¸g»{ª¾¥\¯à°h¤Æ«áªº¤ÏÀ³¡C
¡@¡@³æ¦¸©Î³W«ß¹B°Ê¯à°÷§ïµ½µJ¼{©Mªq³à¡A¦b¬ü°ê¨­Å鬡°Ê«ü¾É¬ì¾Ç©e­û·|ªººî¦X¤ÀªR³ø§i¤¤¡A¤U¦Cµ²½×¨ã¦³¥R¥÷ªºÃÒ¾Ú (2018 PAGAC, 2018)¡G
¡]1¡^ ¨­Å鬡°Ê¯à§ïµ½µJ¼{ªÌªºµJ¼{¯gª¬¡A¤]´î§Cªq³àªÌªºªq³à¯gª¬¡C
¡]2¡^ ¨­Å鬡°Ê¯à´î§C¿©±wªq³àªº­·ÀI¡C
¡]3¡^ ³æ¦¸¹B°Ê¥i¥H´î§Cª¬ºAµJ¼{¡A³W«ß°Ñ»P¤¤¦Ü°ª±j«×ªø®É¶¡°Ñ»P¨­Å鬡°Ê¡A¥i¥H´î§C¦¨¦~¤H©M¦Ñ¦~¤HªºµJ¼{¡C

2. §ïµ½ºÎ¯v«~½è
¡@¡@¦³¶V¨Ó¶V¦h¬ã¨sÅã¥ÜºÎ¯v«~½è©Mªü¯÷®üÀq¯g¦³Ãö¡A¦Ó¬O¬Û¤¬¼vÅT (Drogos et al., 2016)¡Cªø´ÁºÎ¯v«~½è¤£¨Î¥]¬A¤JºÎ®É¶¡©µªø¡BºÎ¯v«~½è¤£¨Î©M²M¿ôªº®É¶¡¼W¥[µ¥¡A·|¼vÅT¦Ñ¦~¤H¥Õ¤Ñ¥Í¬¡¥\¯à¡C¥¿±`ªººÎ¯v¥i¥H±Æ°£¯«¸g¬¡°Ê©Ò²£¥Íªº¬rª«¡A¦Ó¦³¯q¸£³¡°·±d¡A¯«¸g¬rª«ªº»E¶°¬Oªü¯÷®üÀq¯g(AD) ±wªÌªº¤@­Ó¯S¼x¡A©Ò¥H¥¿±`ºÎ¯v³Q»{¬°¬O´î¤Ö¿©±wAD (Drogos et al., 2016) ªº¤@ºØ¤èªk¡C³W«ß¦³®ñ¹B°Ê¥i¥H§ïµ½°ªÄ֪̪ººÎ¯v«~½è¡A¨­Å鬡°Ê¸û¦hªº¤¤¦Ñ¦~¤H»P¦³¸û¨ÎªººÎ¯v«~½è¦³Ãö (U.S. Department of Health and Human Service, 2018)¡C ÀHµÛ¦~ÄÖªº¼W¥[¡AºÎ¯v«~½è·|³vº¥ÅÜ®t¡A¥i¯à·|Åý¸£³¡§ó®e©ö¨ü¨ì¯«¸g¬r¯Àªº¶Ë®`¡C
¡@¡@¬ü°ê¨­Å鬡°Ê«ü¾É¬ì¾Ç©e­û·|³ø§i®Ñ«ü¥X¡A³æ¦¸¹B°Ê©Î³W«ß¹B°Ê¯à°÷§ïµ½ºÎ¯v«~½è (¥R¨¬ÃÒ¾Ú)¡C³W«ß¹B°ÊªÌºÎ±o§ó¦n¡B·Pı§ó¦n©M¥Í¬¡¥\¯à§ó¦n¡A¥i§ïµ½ºÎ¯v«~½è©M¼W¥[¼ôºÎ®É¶¡¡A¦Ó¥B´î¤Ö¼ôºÎ«eªº®É¶¡¡B°_§É«e²M¿ô®É¶¡©M¥Õ¤Ñ©üºÎ¡A¦Ó³æ¦¸¹B°Ê¥ç¦³§ïµ½ºÎ¯v«~½èªº®ÄªG¡A¦¹¥~¡A°Ñ»P§ó¦hªº¤¤°ª±j«×¹B°Ê¡AºÎ¯v«~½è´£¤Éªºµ{«×§ó¤j (2018 PAGAC¡A2018)¡C

¸v¡B¹B°Ê«ü¾É­ì«h»P¬ÛÃö¬ã¨s

¡@¡@¥»¸`¦C¥X¨â½g¹B°Ê°V½m¦³Ãöªº¬ã¨s¤åÄm¡A¥H¤F¸Ñ³æ¦¸¹B°Ê©Mªø®É¶¡°V½mªº¤º®e»P®ÄªG¡A¦A´£¨Ñ¾ãÅé©Êªº¹B°Ê«ü¾É­ì«h»P«ØÄ³¡C

¤@¡B¬ÛÃö¬ã¨s

1. ³W«ß¦³®ñ¹B°Êªº®ÄªG
¡@¡@¾ÇªÌ (Erickson et al., 2011) ¥H120¦ì¨S¦³¹B°Êªº¦Ñ¦~¤H¬°¬ã¨s¹ï¶H¡AÀH¾÷¤À¬°¨â²Õ¡A¤@²Õ¬°¦³®ñ¹B°Ê²Õ¡A¤@²Õ¬°±±¨î²Õ (±q¨Æ¦ù®i¾Þ©M»´·L¬¡°Ê)¡C¦³®ñ¹B°Ê²Õªº¨ü¸ÕªÌ±q¨Æ¤@¦~¡A¨C¶g¤T¤Ñªº¨«¸ô¹B°Ê¡A¶}©l°V½mªº«ùÄò®É¶¡¬°10¤ÀÄÁ¡A¥H«á¨C¶g¼W¥[5¤ÀÄÁ¡Aª½¨ì¯à°÷«ùÄò40¤ÀÄÁ¬°¤î¡A«e¤C¶gªº¹B°Ê±j«×¤¤µ¥¬°50-60%¤ß¸õ²v«O¯d­È (heart rate reserved, HRR)¡A©ó²Ä¤K¶g«á±j«×³vº¥¼W¥[¨ì60-75% HRR¡A¥H³vº¥¼W¥[«ùÄò®É¶¡©M¹B°Ê±j«×ªº¤è¦¡¶i¦æ¡C¬°´Á¤@¦~ªº¦³®ñ°V½mµ²ªG¡A¼W¥[¤F¦Ñ¦~¤Hªº³Ì¤jÄá®ñ¶q7.78%¡B¯«¸gÀç¾iª« (BDNF) 11%©M®ü°¨°j®e¿n2%¡A¤]¼W¥[ªÅ¶¡°O¾Ð¤O¡A¦Ó±±¨î²Õ¦Ñ¦~¤H¤U­°®ü°¨°j®e¿n1.4%¡C ¤@¦~¨C¶g¤T¦¸ªº¦³®ñ°V½m¥i¥H¨ã«OÅ@¸£³¡¥\¯à¡A¥i¥H§áÂà®ü°¨°j¨C¦~1-2%ªº®e¿n¤U­°¡A®ü°¨°j®e¿nªº¼W¥[»P³Ì¤jÄá®ñ¶q©ÎBDNF¦³¬ÛÃö¡C

2. ³æ¦¸¦³®ñ¹B°Ê»Pªý¤O°V½mªº®ÄªG
¡@¡@¾ÇªÌ (Tsai et al., 2018) ±´°Q³æ¦¸¦³®ñ¹B°Ê©Mªý¤O¹B°Ê¹ï»{ª¾ªí²{©M¥Íª««ü¼Ð (¦p BDNF, IGF-1, VEGFµ¥) ªº¼vÅT¡C¥H66¦ì±w¦³»´«×¿ò§Ñ»{ª¾»Ùê¦Ñ¦~¤H¬°¹ï¶H¡AÀH¾÷¤À¬£¦Ü¦³®ñ¹B°Ê²Õ¡Bªý¤O¹B°Ê²Õ©M±±¨î²Õ¡A©ó¹B°Ê«e«á´ú¶q¬ÛÃö»{ª¾ªí²{©M¥Íª««ü¼Ðµ¥¨ÌÅܶµ«ü¼Ð¡C
¡@¡@³æ¦¸¦³®ñ¹B°Êªº¤º®e¡G¥H©T©w¸}½ñ¨®¬°¹B°Ê¤è¦¡¡A¤¤µ¥¹B°Ê±j«×¡A¬ù¬°¨C¤H¤ß¸õ²v«O¯d­Èªº65-75%¡A«ùÄò¹B°Ê30¤ÀÄÁ¡C³æ¦¸ªý¤O°V½mªº¤º®e¡G¥H©T©w¾÷±ñ©Î²¾°Ê¦¡¾¹§÷¬°¤è¦¡¡A¤¤µ¥¹B°Ê±j«×¡A­t²ü¬ù75%³Ì¤j­t²ü (75% 1 RM)¡A¨C­Ó°Ê§@¤ÏÂаV½m10¦¸¡A±q¨Æ¨â¦^¦X¡A¦^¦X¤§¶¡¥ð®§90¬í¡A°Ê§@»P°Ê§@¤§¶¡¥ð®§¨â¤ÀÄÁ¡A«ùÄò¹B°Ê30¤À¡C­«°V°Ê§@¥]¬AªÐ¤GÀY¦Ù©}Á|¡BªÐ¤TÀY¦Ù¦ù®i¡B¥õª×±ÀÁ|¡BÂù»L±ÀÃÞ¡B¤j»L¦ù®i (leg extension) ©Mª½¥ßÂX¯Ý¹B°Ê (vertical butterflies) µ¥¡C¸}½ñ¨®©Î­«°V¹B°Ê«e¦³5¤ÀÄÁªº¼ö¨­¡A30¤À¹B°Ê«á¦³5¤ÀÄÁªº½w©M¬¡°Ê¡C
¡@¡@µ²ªG¡G(1)³æ¦¸¦³®ñ¹B°Ê©Îªý¤O¹B°Ê¤£¦ý·|ÅãµÛ§ïµ½»{ª¾¦æ¬°ªí²{ (¦p¤ÏÀ³®É¶¡)¡A¤]·|¼W¥[¹q¤l¥Í²z«ü¼Ð (¦p¨Æ¥ó¬ÛÃö¹q¦ì ERP P3¾_´T)¡A³æ¦¸¦³®ñ¹B°Ê¼W¥[¦å²GBDNF»PIGF1ªº¿@«×¡A¦Óªý¤O°V½m¼W¥[IGF1¿@«×¡A¦Ó³o¨Ç§ïµ½®ÄªG©ó¹B°Ê«á20¤ÀÄÁ´N·|¦^¨ì°ò¦ÂI¡C(2)³æ¦¸30¤ÀÄÁªº¦³®ñ¹B°Ê©Îªý¤O°V½m¹ï»{ª¾»´«×»Ùê¦Ñ¦~¤Hªº¸£³¡»{ª¾ªí²{»P¥Íª««ü¼Ð¦³¥¿­±ªº®ÄªG¡C

¤G¡B¨­Å鬡°Ê«ü¾É­ì«h»P«ØÄ³

¡@¡@¹L¥h¬ã¨s«ü¥X¨­Å鬡°Ê¹ï©ó°ªÄ֪̪º¸£³¡°·±d¦³³\¦h¯q³B¡A¦ý§ïµ½¸£³¡°·±dªº¹B°Ê³B¤èÁÙ¤£«Ü©ú½T¡A¨ãÅ骺¹B°Ê¤è¦¡¡B±j«×¡BÀW²v»P«ùÄò®É¶¡³£¦³«Ý¶i¤@¨B¬ã¨s (Erickson et al., 2019)¡C¥»¤å°Ñ¦Ò¬ÛÃö¤åÄm (¤è¶i¶©¡A2015; U.S. Department of Health and Human Service, 2018; Garber et al., 2011)¡A´£¨Ñ¤@¨Ç¨­Å鬡°Êªº«ü¾É­ì«h»P«ØÄ³¡A§Æ±æ¦³§U©ó°ÊºA¥Í¬¡¤è¦¡©Î³W«ß¹B°Ê²ßºDªº¾i¦¨¡C°ò¥»¤W¡A¹B°Ê³B¤è©Î­pµeªº³]­p·|¦Ò¶q¤­­Ó¦]¯À (MRFIT)©Mª`·N¨Æ¶µ¡A§Y¹B°Ê¤è¦¡ (Mode)¡Bº¥¶i­t²ü (Rate of Progression)¡B¹B°ÊÀW²v (Frequency)¡B¹B°Ê±j«× (Intensity) ©M«ùÄò®É¶¡ (Time)¡A¤]­n¦Ò¶qª`·N¨Æ¶µ¡A¦p¹B°Ê¦w¥þµ¥°ÝÃD (¤è¶i¶©¡A2019)¡C

1. ¹B°Ê¤è¦¡
¡@¡@°Ñ»P¦h¤¸¹B°Ê¡A¥H¦³®ñ¡Bªý¤O©M¥­¿Å¹B°Ê¬°¥D¡A¥]¬A¨ä¥L¨­Å鬡°Ê¡A¦p¦ù®i¾Þ¡B¨­¤ß¹B°Ê (¦p¤Ó·¥¡B·ì¦÷) ©M²yÃþ¹B°Êµ¥¡C¦p°ªÄ֪̦³¥­¿Å¦³°ÝÃD¡A¥ý±q¨Æªý¤O©M¥­¿Å°V½m«á¡A¦A°Ñ»P¦³®ñ¹B°Ê¡C¨«¸ô¬O«Ü¾A¦X°ªÄ֪̪º¦³®ñ¹B°Ê¤§¤@¡A¥i¥H§ïµ½³Ì¤jÄá®ñ¶q¡Cªý¤O¹B°Ê¥i§Q¥Î¦Û¨­Åé­«©Î²©ö¾¹§÷¬°­t²ü¡A¤è«K¦b¤é±`¥Í¬¡¤¤¹ê¬I¡A¥H´£¤É¦Ù¦×¾A¯à¡C¿ï¾Ü¦Û¤v³ßÅw©M¤è«Kªº¹B°Ê¡A¸û®e©ö¾i¦¨³W«ß¹B°Ê²ßºD©Î°ÊºA¥Í¬¡¤è¦¡¡C

2. º¥¶i­t²ü
¡@¡@­n½wºCªº¼W¥[­t²ü¡A¹F¨ì¨C¶g¦Ü¤Ö±q¨Æ¤¤µ¥±j«×¦³®ñ¹B°Ê150-300¤ÀÄÁ¡A©Î¬O¿E¯P¦³®ñ¹B°Ê¨C¶g75-150¤ÀÄÁªº¥Ø¼Ð¡A¤]¥i¥H¤¤«×©Î¿E¯P±j«×²V¦X°V½m¡Cº¥¶i­t²ü­n¦Ò¶q­Ó§O®t²§¡A¦pªG°·±dª¬ªp©ÎÅé¯à¤£¨Î¡A«h­n±Ä¨ú¸û¬°«O¦uªº¤è¦¡¹ê¬I¡CÁöµM¤¤µ¥©Î¿E¯P±j«×¹B°Ê¹ï©ó¸£³¡°·±d¸û¦³¯q³B¡A¦ý¨Ã¤£¬O¨C¤H¬Ò¾A¦X±q¨Æ³o¼Ëªº¹B°Ê¡A¦p¦³ºC©Ê¯e¯f©Î¸û¬°µê®z¡A¶}©l¥u¯à±q¨Æµu®É¶¡¸û»´·Lªº¬¡°Ê¡A¦p¥ÑºC¨«¤­¤ÀÄÁ¶}©l¡AµM«áºCºCªº¼W¥[¹B°Ê±j«×¡B®É¶¡©ÎÀW²v¡Cªý¤O°V½m¤]­n¨Ì¾Úº¥¶i­ì«h¡AºCºCªº¼W¥[­t²ü©Î°V½m¶q¡AÅý¨­Å馳¨¬°÷®É¶¡¾AÀ³«á¡A¦A¼W¥[­t²ü¡C

3. ¹B°ÊÀW²v
¡@¡@¨C¶g±q¨Æ¦Ü¤Ö¤­¤Ñ¤¤µ¥±j«×©Î¦Ü¤Ö¤T¤Ñ¿E¯P±j«×ªº¦³®ñ¹B°Ê¡A¦Óªý¤O°V½m¨C¶g¦Ü¤Ö¨â¤Ñ¡C¦pµLªk«ùÄò«ùªø®É¶¡¦³®ñ¹B°Ê (¦p¤T¤Q¤ÀÄÁ¨«¸ô)¡A¥i¥H¦b¤@¤Ñ¤§¤º¤À¬q¹ê¬I (¦p¤À¤T¦¸¨«¸ô¡A¨C¦¸¤Q¤ÀÄÁ)¡A¥i¥H¹F¨ì¦P¼Ëªº¹B°Ê®ÄªG¡C¦p°·±d©MÅé¯àª¬ªp³\¥i¡A¨­Å鬡°Ê¯à°÷¶W¹L«ØÄ³¶q (¦p¤¤µ¥±j«×¦³®ñ¹B°Ê150-300¤ÀÄÁ)¡A¥i¥HÀò±o§ó¦hªº®ÄªG¡A©Ò¥H¯à°÷¨C¤Ñ¬Ò±q¨Æ¾A«×¹B°Ê¡A®ÄªG§ó¨Î¡C

4. ¹B°Ê±j«×
¡@¡@¹B°Ê±j«×­n¾A·í¡G°ªÄ֪̫ØÄ³¥Î¡u¹B°Ê¦Ûı¶qªí¡v¨Óªí¥Ü¬Û¹ïªº¹B°Ê±j«×¡A¦b0-10ªº¶qªí¤¤ (0¥Nªí³Ì»´ÃP¡A10¥Nªí³Ì¿E¯P)¡A5-6¥Nªí¤¤µ¥±j«×¡A¹Lµ{¥i¥HÁ¿¸Ü¡A¦Ó7-8¥Nªí¿E¯P±j«×¡A¹Lµ{µLªkÁ¿¸Ü¡C¹B°Ê±j«×»Ý­n¦Ò¶q­Ó§O®t²§¡A¦³ºC©Ê¯e¯f©ÎÅé¾A¯à¸û®tªº¤H¡A©y±Ä¨ú¡u§C±j«×µu®É¶¡¡vªº¹B°Ê¡C¶}©l¹B°Ê®É¡A¹B°Ê±j«×©Î­t²ü­n§C¡A¤£­n«j±j¡AÅý¨­Åé³vº¥¾AÀ³«á¦A¼W¥[¹B°Ê±j«×¡C¦b¡u¤£¯kµh¡vªº­ì«h¤U¹B°Ê¡A¦pªGı±o¨­Åé·|¯kµh¡A«hªí¥Ü¹B°Ê±j«×¤Ó°ª¡A»Ý­n´î§C±j«×©Î°±¤î¹B°Ê¡A§_«h®e©ö²£¥Í¹B°Ê¶Ë®`©M¤£´r§Öªº¸gÅç¡A¤£©ö¾i¦¨¹B°Ê²ßºD¡C

5. «ùÄò®É¶¡
¡@¡@¨C¦¸¤¤µ¥±j«×¦³®ñ¹B°Ê«ùÄò30-60¤ÀÄÁ¡A¿E¯P±j«×¦³®ñ¹B°Ê«ùÄò20-30¤ÀÄÁ¡A¸û¦hªº¨­Å鬡°Ê¥i¥H´î§C¥¢´¼­·ÀI©M§ïµ½»{ª¾¥\¯à¡A©Ò¥H³vº¥¼W¥[¨C¦¸ªº¹B°Ê«ùÄò®É¶¡¡A±N¦³§U¨­Å鬡°Ê¶qªº¼W¥[¡C¦Ó«ùÄò®É¶¡¤]»Ý­nºCºCªº¼W¥[¡A­ì«h¤W©ó°V½m¨â¦Ü¤T¶g«á¡A¦A¼W¥[¹B°Ê­t²ü¡A´T«×¬ù¼W¥[5-10%¡A°ªÄ֪̪º¾AÀ³®É¶¡¤ñ¦~»´¤H­n¤[¡A¼W¥[ªº«ùÄò®É¶¡¤]¤£­n¤Ó¦h¡C¨C¦ì°ªÄ֪̭n¦Ò¶q¦Û¤vÅé¾A¯àª¬ªp¡A¿ï¾Ü¾A¦Xªº«ùÄò®É¶¡»P¹B°Ê±j«×¶}©l¹B°Ê¡AµM«áºCºC¼W¥[«ùÄò®É¶¡¡A¤@¬q®É¶¡«á¡A¦ÛµM´N·|¹F¨ì¨C¦¸¤T¤Q¤ÀÄÁ¥H¤W¡C°ªÄ֪̥H¸û§C±j«×¡A¯à±q¨Æ¸ûªø®É¶¡ (¦p¤T¤Q¤À¥H¤W) ªº¦³®ñ¹B°Ê«á¡A¦A¼W¥[±j«×¸û¬°²z·Q¡A¦]¨ã¦³¤ßªÍ­@¤O°ò¦«á¡A¦A¼W¥[¹B°Ê±j«×¡A¸û¤£®e©ö³y¦¨¹B°Ê¶Ë®`¡C

6. ª`·N¨Æ¶µ
¡@¡@°£¤FMRFIT¥~¡A¬ü°ê¹B°ÊÂå¾Ç·|«ØÄ³­n¦Ò¶q¨­Å鬡°Ê¶q (volume) ©M§ÎºA (pattern) ¨â­Ó¦]¯À¡A¥H¼W¥[¹B°Ê®ÄªG©Î¥i¦æ©Ê (Garber et al., 2011)¡C¦Ó¹B°Ê¦w¥þ©M³W«ß¹B°Ê²ßºDªº¾i¦¨¤]¬O¹B°Ê­pµeªº­«ÂI¡C

(1) ¼W¥[¨­Å鬡°Ê¶q
¡@¡@¨­Å鬡°Ê¶q¥]¬A¹B°Ê»P¤é±`¨­Å鬡°Ê¡A¤W­zªºMRFIT¡A¬Oµ²ºc¦¡©Î¶Ç²Î¦¡ªº¹B°Ê¤¶¤J¤º®e¡A¹ï©ó´£¤ÉÅé¾A¯à»P°·±dª¬ªp¬Ò«Ü¦³®ÄªG¡A¦ý¬O¤é±`¨­Å鬡°Ê¬O¥Í¬¡¤è¦¡ªº¤¶¤J¡A¹ï©ó°·±d«P¶i¤]«Ü­«­n¡A«Ü¾A¦X°ªÄ̡֪C¨­Å鬡°Ê¶q¶V¦h¡AÅé¾A¯à»P°·±dª¬ªp¶V¦n¡A©¼¦¹¤§¶¡¦³¬ÛÃö¡C¨­Å鬡°Ê¶q¥i¥H¥Î³\¦h¤è¦¡ªí¥Ü¡A­p¨B¾¹¬O¤@ºØ¤è«K©M¹ê¥Îªº¤èªk¡A¥i¥H¤F¸Ñ¨C¤Ñ¨­Å鬡°Ê¶q¦h¹è¡AµM«á­q©w¦X²zªº¥Ø¼Ð¡A®e©ö¦Û§ÚºÊ·þ©M¿EÀy¡A¦Ó³vº¥¼W¥[¨­Å鬡°Ê¶q¡C¼W¥[¨­Å鬡°Ê©Mº¥¤ÖÀRºA¥Í¬¡¤è¦¡¬O°·±d«P¶iªº­ì«h¡A§Æ±æ°ªÄ֪̯à°÷ºû«ù¤é¦æ¤@¸U¨Bªº¥Ø¼Ð¡A¦pªG¦]¬°°·±d»PÅé¯àª¬ªpµLªk¹F¨ì³o¥Ø¼Ð¡A¦ý¥u­n¤ñ­ì¨Óªº¨­Å鬡°Ê¶q¦h¡AÁÙ¬O¥i¥HÀò±o°·±d¯q³Bªº¡C

(2) ±Ä¥Î¾A¦Xªº¹B°Ê«¬ºA
¡@¡@±q¨Æ¦³®ñ¹B°Ê¦Ü¤Ö30¤À¬O§ïµ½¤ßªÍ¥\¯àªº«ØÄ³¡A¦ý³\¦h°ªÄ̵֪Lªk«ùÄò¹B°Ê¨º»ò¤[¡A¦]¦¹¥i¥H¦Ò¶q¦Û¤vªºª¬ªp¡A¦Ó±Ä¨ú¾A¦Xªº«¬ºA¨Ó¹ê¬I¡C¤À¬q¹B°Ê©M«ùÄò¹B°Ê®ÄªG¬O¤@¼Ëªº¡A¥i¦b¤£¦Pªº®É¬q¹B°Ê¦Ó²Ö¿n®É¶¡¡A¦p¤À¤T¦¸¹B°Ê¡A¨C¦¸¨«¸ô¤Q¤ÀÄÁ¡AÁ`¦@¹B°Ê¤T¤Q¤ÀÄÁ¡C¦¹¥~¡A°ª±j«×¶¡·²¹B°Ê¤]¥i¥H±Ä¥Î¡A¥H´î¤Ö°V½m®É¶¡©M¼W¥[°V½m®ÄªG (¤è¶i¶©¡A2019)¡A·íµM¨Ã¤£¬O©Ò¦³ªº°ªÄ֪̬ҾA¥Î³oºØ«¬ºA¡A»Ý­n³W«ß¹B°Ê¤@¬q®É¶¡ (¦p¤T­Ó¬P´Á)¡A¨ã¦³°ò¥»Åé¯à«á¦A¹ê¬I¡A¦p¥­®É¨«¸ô30¤ÀÄÁ¹Lµ{¤¤¡A¥i¥H¦³3¦¸ªº®É¶¡¨«µy·L§Ö¤@ÂI¡A¦Ó«ùÄò20-30¬í¡AµM«á¦A¦^¨ì¨«¸ô2-3¤ÀÄÁ¡A¦Aµy·L§Ö¨«20-30¬í¡A¦p¦¹¤ÏÂÐ3¦¸¡A°ª±j«×¶¡·²°V½m¦³³\¦hªº«¬ºA¡A¦p¹B°Ê±j«×¡B«ùÄò®É¶¡©M¥ð®§®É¶¡ªº³W¹º¬Ò¥i¦Ò¶q¨C­Ó¤Hªºª¬ªp¡A¦Ó¦b¾A«×ªº½Õ¾ã¡C

(3) ½Ð±Ð±M·~·ÓÅ@¤H­û
¡@¡@¤j³¡¤Àªº°ªÄ֪̦³¦Ü¤Ö¤@ºØºC©Ê¯e¯f (U.S. Department of Health & Human Service, 2018)¡A¦p¦³ºC©Ê¯e¯f¡A©ó¹B°Ê«e¥ý½Ð±ÐÂå®v©Î±M·~·ÓÅ@¤H­û¦³Ãö¹B°Ê¨Æ©y¡A½Ð±Ð¦p¦ó¦w¥þ±q¨Æ¨­Å鬡°Ê¡AÁA¸Ñ¹B°Ê¹ï©ó³o¨Ç¯e¯fªº¼vÅT©M¯q³B¡C¦p¦³ºC©Ê¯e¯f©Î°·±d¤£¨Î¡AµLªk¹F¨ì150¤À¤¤µ¥±j«×ªº¦³®ñ¹B°Ê¡A­n¦b¥i¥H§Ô¨üªº¦w¥þ±¡ªp¤U¡A¼W¥[¨­Å鬡°Ê¶q¡A´î¤ÖÀRºA¥Í¬¡¤è¦¡¡C

(4) ¼ö¨­»P½w©M¹B°Ê
¡@¡@¹B°Ê«eªº¼ö¨­©M¹B°Ê«áªº½w©M¹B°Ê¬O»Ý­nªº¡A¤£¦ý¥i¥H´î¤Ö¹B°Ê¶Ë®`¡A¤]¦³§U¥þ¨­Ãö¸`¦ù®i¡C°ªÄ֪̪º¼ö¨­»P½w©M¹B°Ê¬ù5-10¤ÀÄÁ¡A¶}©l®ÉºCºCªº¬¡°Ê¦ù®i¡A¨­Åé·x©M«á¡A¦A³vº¥¼W¥[¹B°Ê±j«×¡A»Ý­n®É¥i¥H¼W¥[¼ö¨­¹B°Ê®É¶¡¡C

(5) ¤£¯kµh­ì«h
¡@¡@¨C­Ó¤Hªº°·±d©MÅé¯àª¬ªp¤£¦P¡A¹B°Ê¹Lµ{­n¥H¡u¤£¯kµh¡v¬°¨Ì¾Ú¡A¦p¨­Åé·|·Pı¯kµh©Î¤£µÎªA¡A´N­n°±¤î¹B°Ê©Î´î§C¹B°Ê±j«×¡AÅý¯kµh®ø¥¢¡A§_«h®e©öµo¥Í·N¥~¡A¤]·|¦³¤£´r§Öªº¸gÅç©Î·P¨ü¡A§«Ãª¹B°Ê²ßºDªº¾i¦¨¡C

(6) ©M¿Ë¤Í¤@°_¹B°Ê
¡@¡@ªÀ·|¤ä«ù¥i¥H¼W¥[¨­Å鬡°Ê¾÷·|¡A©M®a¤H©Î¿Ë¤Í¤@°_¹B°Ê¡A¥i¥H¼W¥[¤H»Ú¤¬°Ê©M¹B°Ê°Ê¾÷¡C°·±d©ÎÅé¯à¸û®tªº°ªÄ̡֪A¦³¿Ë¤Í³­¦ñ·|¸û¦³¦w¥þ·P¡A¦Ó¼W¥[¹B°Êªº·NÄ@¡C

(7) ¦w¥þÀô¹Ò
¡@¡@¹B°Ê®É­nª`·NÀô¹Ò¦w¥þ¡A¥H´î¤Ö¹B°Ê¶Ë®`¡C¹B°ÊªºÀô¹Ò­nÁ×§K¦a­±Àã·Æ¡B¿O¥ú©ü·t¡B¦a­±¤£¥­©Î¤H¼é¾ÖÀ½µ¥ª¬ªp¡A¥HÁ×§K¶^­Ë¡C¦p¦³ÀH®É¥i¥H¤ä«ùªº®à´È¡BÀ𭱩ΧßÄæ¡A¬Ò¥i¥H¼W¥[¹B°Êªº¦w¥þ©Ê»P°Ê¾÷¡C

(8) ¾i¦¨³W«ß¹B°Ê
¡@¡@¯à³W«ß¨­Å鬡°Ê¤~¯àÀò±o¯q³B¡A³\¦h°ªĄ֪̈­Å鬡°Ê¶q¤£¨¬¡A¦p¦ó§ïÅܹB°Ê¦æ¬°¬O¹B°Ê­pµe³Ì¥D­nªº¥Ø¡A©Ò¥H¦b¹ªÀy©Î«ü¾É°ªÄ֪̹B°Ê®É¡A­n¥R¤ÀÀ³¥Î¦æ¬°§ïÅܪkªº²z½×»Pµ¦²¤¡A´£¤É¦Û§Ú®Ä¯à©M¤º¦b°Ê¾÷¡A¾i¦¨³W«ß¹B°Ê²ßºD¡C

¥î¡Bµ²»y

¡@¡@³W«ß¨­Å鬡°Ê¹ï©ó¸£³¡°·±d¤w³QÃҹ꦳¬Û·í¦hªº¯q³B¡A³z¹L³\¦h¾÷Âà§ïµ½¦Ñ¤Æ©Ò±a¨Óªº­t­±®ÄªG¡A¥]¬A§ïµ½³Ì¤jÄá®ñ¶q¡B¸£¦å¬y¶q¡B¸£µ²ºc¡B®ñ¤ÆÀ£¤O¡B¤ß¦åºÞ¦MÀI¦]¯À©MºÎ¯v«~½èµ¥¥Í²z¡B¥Íª«©M¤ß²z«ü¼Ð¡A¦]¦Ó¹w¨¾©Î©µ¿ð¥¢´¼¯gª¬ªºµo¥Í (Tyndall et al., 2018)¡C°£¤F³o¨Ç¥¿­±®Ä¯q¥~¡A³W«ß¹B°ÊÁÙ¦³³\¦h¦n³B¡A¥]¬A´£¤É¥þ¤H°·±d¡B´£¤É¨­Åé¥\¯à¡B´î¤Ö¯e¯f¿©±w²v»P¦º¤`²v¡A©Mºû«ù¿W¥ß¦Û¥Dªº¥Í¬¡¤è¦¡¡A³o¨Ç³£¬O¦¨¥\¦Ñ¤Æ§Æ±æ¾Ö¦³ªº¯S½è¡C

¡@¡@Áp¦X°ê½Ã¥Í²Õ´©M¬ü°ê°·±dªA°È³¡¦b¡u¥þ²y°·±d»P¦Ñ¤Æ¡v³ø§i®Ñ¤¤«ü¥X¡G2010¦~¥þ²y65·³¥H¤W¤H¤f¬ù8%, ¨ì2050¦~¹w¦ô·|¼W¥[¨ì16%¡A©IÆ~¥þ²y¦U°ê­n­«µø¦Ñ¤ÆÄ³ÃD (WHO, 2011)¡A¤Î¦­´£¥X¦³®Äªºµ¦²¤¨Ó­±¹ï¡A¥]¬A¥¢´¼°ÝÃD¡C³\¦h¤èªk»Pµ¦²¤¬Ò¦³§U©ó¸£³¡°·±d¡A¦Ó°·±d¥Í¬¡¤è¦¡¤w³Q»{¬°¬O¹w¨¾©Î©µ¿ð¥¢´¼¯gª¬ (Tyndall et al., 2018) ªº­«­n¤èªk¡A¦]¦¹¡A°£³W«ß¹B°Ê¥~¡A¤]­n­ÝÅU°·±d¶¼­¹¡B¥R¤ÀºÎ¯v¡B«O«ù¾Ç²ß (¨ë¿E¸£³¡)¡B¥¿¦V«ä¦Ò©M¤H»Ú¤¬°Êµ¥¤èªk¡C

¡@¡@¡u¹B°Ê´N¬O¨}ÃÄ (Exercise is Medicine)¡v³o¬O¬ü°ê¹B°ÊÂå¾Ç·|ªº±À¼s¤f¸¹¡A§Æ±æÂå®v¯à±N¹B°Ê³B¤è¿Ä¤J¯e¯fªvÀøªº¤èªk¤§¤@¡C¥Ø«e¤j³¡¤Àªº°ªĄ֪̈S¦³³W«ß¹B°Ê²ßºD¡A¨S¦³¹F¨ì«ØÄ³ªº¨­Å鬡°Ê¡A¦]¦¹¡A­±¹ï¤é·UÄY­«ªº¥¢´¼¯g«Â¯Ù¡A´X­Ó°ÝÃD­È±o§Ú­ÌÂÔ·Vªº«ä¦Ò¡A¹w¨¾¥¢´¼¯gªº­«­n¤è¦V©Îµ¦²¤¬O¤°»ò¡H¤°»ò¬O¹w¨¾¥¢´¼¯g³Ì¨ã¦¨¥»®Ä¯qªº¤èªk¡H¦p¦ó¼W¥[°ªÄ֪̾i¦¨³W«ß¹B°Ê²ßºD¡H¤°»ò¬O§ïµ½¸£³¡°·±dªº¹B°Ê³B¤è¡H ¥»¤åÂÔ´£¨Ñ³Ìªñªº°ê¤º¥~¬ÛÃö¬ã¨sµ²ªG»P«H®§¡A§Æ±æ¦bÃö¤ß°ªÄ̸֪£³¡°·±dijÃD®É¡A¯à¦Ò¶q¨­Å鬡°Ê»P¹B°Êªº­«­n©Ê¡A¦Ó¦C¤J­«­nµ¦²¤¡A§ë¤J§ó¦hªº¸ê·½»P¤H¤O¦b³o­Ó»â°ì¡A±q¨Æ§ó¦hªº¬ã¨s¡B«Å¾É»P±À¼sµ¥¤u§@¡A¦ÓÀ°§U§ó¦h¤H¾i¦¨³W«ß¹B°Ê²ßºD¨ÃÀò±o°·±d¡C

°Ñ¦Ò¤åÄm

»OÆW¥¢´¼¯g¨ó·| (2018)¡C¥¢´¼¤H¤fª¾¦h¤Ö¡C¨ú¦Ûhttp://www.tada2002.org.tw/tada_know_02.html

¤è¶i¶© (2015)¡C°ªÄ֪̪º¹B°Ê»P¥þ¤H°·±d¡C¥x¥_¥«¡GµØ³£¡C

¤è¶i¶© (2019)¡C¹B°Ê³B¤è(¤Gª©)¡C¥x¥_¥«¡GµØ³£¡C

Physical Activity Guidelines Advisory Committee. (2018). Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: U.S. Department of Health and Human Service.

World Health Organization., & U.S. Department of Health and Human Service. (2011). Global Health and Aging. Retrieved from https://www.who.int/ageing/publications/global_health.pdf

World Health Organization. (2015). what is healthy ageing. Global Health and Aging. Retrieved from https://www.who.int/ageing/healthy-ageing/en/

U.S. Department of Health and Human Service. (2018). Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Service.

Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., Macvicar, B. A., & Newman, E. A. (2010). Glial and neuronal control of brain blood flow. Nature, 468, 203-243.

Birdsill, A. C., Carlsson, C. M., Willette, A. A., Okonkwo, O. C., Johnson, S. C., Xu, G., ... Bendlin, B. B. (2013). Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity, 21(7), 1313-1320.

Bouazizw, W., Vogelt, T., Schmitte, E., Kaltenbachg, G., Geny, B., & Lang, P. O. (2016). Challenges to successful aging: recommendation and new trends in the field of aging and physical activity. Austin Sports Medicine, 1(2), 1009.

Brown, A. D., McMorris, C. A., Longman, R. S., Leigh, R., Hill, M. D., Friedenreich, C. M., & Poulin, M. J. (2010). Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women. Neurology, 31(12), 2047-2057.

Buchman, A. S., Boyle, P. A., Yu, L., Shah, R. C., Wilson, R. S., & Bennett, D. A. (2012). Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology, 78(17), 1323-1329.

Colbert, L. H., Visser, M., Simonsick, E. M., Tracy, R. P., Newman, A. B., Kritchevsky, S. B., ... Harris, T. B. (2004). Physical activity, exercise, and inflammatory markers in older adults: Findings from the health, aging and body composition study. Journal of the American Geriatrics Society, 52(7), 1098-1104.

Davenport, M. H., Hogan, D. B., Eskes, G. A., Longman, R. S., & Poulin, M. J. (2012). Cerebrovascular reserve: The link between fitness and cognitive function? Exercise and Sport Sciences Reviews, 40(3), 153-158.

Drogos, L. L., Gill, S. J., Tyndall, A. V., Raneri, J. K., Parboosingh, J. S., Naef, A., ... Poulin, M. J. (2016). Evidence of association between sleep quality and APOE 4 in healthy older adults: A pilot study. Neurology, 87(17), 1839-1842.

Erickson, K. I.,Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., ... Kramer, A. F. (2011). Exercise training in creases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences of the United States of America, 108(7), 3017-3022.

Erickson, K. I., Hillman, C., Stillman, C. M., Ballard, R.M., Bloodgood, B., Conroy, D. E., ... Powell, K. E. (2019). Physical activity, cognition, and brain outcomes, a review of the 2019 physical activity guidelines. Medicine & Science in Sports & Exercise, 51(6), 1242-1251.

Garber, C. E., Blissmer, B., Deschenes, M., Franklin, B. A., Lamonte, M. J., Lee, I., ... Swain, D. P. (2011). Quality and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guideline for prescribing exercise. Medicine & Science in Sports & Exercise, 43(7), 1334-1359.

Gill, S. J., Friedenreich, C. M., Sajobi, T. T., Longman, R. S., Drogos, L. L., Davenport, M. H., ... Poulin, M. J. (2015). Association between lifetime physical activity and cognitive functioning in middle-aged and older community dwelling adults: results from the brain in motion study. Journal of the International Neuropsychological Society, 21(10), 816-830.

Hess, N.C. L., & Smart, N.A. (2017). Isometric exercise training for managing vascular risk factors in mild cognitive impairment and Alzheimer's Disease. Frontiers in Aging Neuroscience, 9, 1-12.

Maass, A., Düzel, S., Brigadski, T., Goerke, M., Becke, A., Sobieray, U., ... Düzel, E. (2016). Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults. Neuroimage, 131(1), 142-154.

Ng, T. P., Feng, L., Nyunt, M. S. Z., Feng, L., Gao, Q., Lim, M. L., ... Yap, K. B. (2016). Metabolic syndrome and the risk of mild ognitive impairment and progression to dementia: follow-up of the ingapore longitudinal ageing study cohort. Neurology, 73(4), 456-463.

Palmer, K., Berger, A. K., Monastero, R., Winblad, B., Bäckman, L., & Fratiglioni, L. (2007). Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology, 68(19), 1596-1602.

Pialoux, V., Brown, A. D., Leigh, R., Friedenreich, C. M., & Poulin, M. J. (2009). Effect of cardiorespiratory fitness on vascular regulation and oxidative stress in postmenopausal women. Hypertension, 54(5), 1014-1020.

Stoquart-ElSankari, S., Baledent, O., Gondry-Jouet, C., Makki, M., Godefroy, O., & Meyer, M. E. (2007). Aging effects on cerebral blood and cerebrospinal fluid flows. Journal of Cerebral Blood Flow & Metabolism, 27(9), 1563-1572.

Ten Brinke, L. F., Bolandzadeh, N., Nagamatsu, L. S., Hsu, C. L., Davis, J. C., Miran-Khan, K., & Liu-Ambrose, T. (2015). Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial. British Journal of Sports Medicine, 49(4), 248-254.

Tsai, C. L., Ukropec, J., Ukropcová, B., & Pai, M. C. (2018). An acute bout of aerobic or strength exercise specifically modifies circulating exerkine levels and neurocognitive functions in elderly individuals with mild cognitive impairment. Neuroimage Clin, 17, 272-284.

Tyndall, A.V., Clark, C.M. , Anderson, T. J., Hogan, D. B., Hill, M. D., Longman, R. S., & Poulin, M.J. (2018). Protective effects of exercise on cognition and brain health in older adults. Exercise & Sport Sciences Reviews, 46(4), 215-223.

¡@¦@¦³ 0 ¦^À³


¡@¡@¦^¤W­¶ ¡@¡@µoªí¦^À³
 B ʥͲz Ǻ
 B ʥͲz Ǻ     Ǥƶ] B V m
 B ʥͲz Ǻ    x W   a V m A ȥ  x
 B ʥͲz Ǻ      Z w   P V m B
    (PFQ) [ c
 B ʥͲz Ǻ    C ֦~    פ  R
 B ʥͲz Ǻ   YouTube W D
°µ­Ó¦³´¼¼zªº¶]ªÌ

¥xÆW¹B°Ê¥Í²zº[Åé¯à¾Ç·|

 j M     ҾǥZ

¹B°Ê¥Í²z¾Çºô¯¸¯»µ·¹Î
¹B°Ê¬ì¾Ç±Ð¨|¬ã¨s«Ç